Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation.
about
Ecto-5'-Nucleotidase Overexpression Reduces Tumor Growth in a Xenograph Medulloblastoma ModelTiclopidine in its prodrug form is a selective inhibitor of human NTPDase1Purine-metabolizing ectoenzymes control IL-8 production in human colon HT-29 cells.Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver.Quinazoline-4-piperidine sulfamides are specific inhibitors of human NPP1 and prevent pathological mineralization of valve interstitial cells.Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.Effects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrelTherapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors.Characterization of ectonucleotidase expression in the rat carotid body: regulation by chronic hypoxia.ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.No effect of clopidogrel activity or cessation on vascular function or markers of inflammation.Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk.CD39/NTPDase-1 expression and activity in human umbilical vein endothelial cells are differentially regulated by leaf extracts from Rubus caesius and Rubus idaeus.Sensory Processing and Integration at the Carotid Body Tripartite Synapse: Neurotransmitter Functions and Effects of Chronic Hypoxia.Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis
P2860
Q27312282-753B38B8-77E1-4954-B0AC-10A469D59358Q34087391-FDF0264D-FA92-4258-B793-433DA32B40E1Q34152663-6BF6843B-E627-4F6E-8F0E-0973AE886ED3Q35780855-3A1718B6-2128-430C-A3CB-9E99C1B80A3FQ35978155-6FB6AB37-91BA-4939-9D73-87C50ACA44CAQ36071796-EB26E0EA-5CF1-4325-9B12-47241646CFC3Q36153265-2D832342-0385-470C-877B-CE294FA854F5Q38151635-EF620354-6B16-4A0F-BB31-39D1ADC2CA1DQ38699486-2C7C9310-849F-4E33-BAB5-744429671396Q41628315-CD39AB60-5872-4BF4-A512-8536D1F97763Q42090585-AD56F47F-B5FA-4EE4-A17B-DC8D963DDC0CQ43102079-4570C5A5-D0A8-4926-87A9-58155A2B737EQ46865570-7FF58B63-F25D-4312-BEE4-E0ED0BCCE107Q54943256-9F6A638D-AAA7-44F6-948F-FFCD49A4A965Q59100784-CDD83080-9348-4FA3-A4CC-A00D45003850
P2860
Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Inhibition of vascular ectonuc ...... favours platelet aggregation.
@en
type
label
Inhibition of vascular ectonuc ...... favours platelet aggregation.
@en
prefLabel
Inhibition of vascular ectonuc ...... favours platelet aggregation.
@en
P2860
P1476
Inhibition of vascular ectonuc ...... l favours platelet aggregation
@en
P2093
Joanna Lecka
Manjit Singh Rana
P2860
P304
P356
10.1111/J.1476-5381.2010.00951.X
P407
P50
P577
2010-11-01T00:00:00Z